Jonathan Charles Derrick Sutch

Title: The Innovations of Jonathan Charles Derrick Sutch

Introduction

Jonathan Charles Derrick Sutch is a notable inventor based in Cheshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of novel co-crystals for medical applications. His work focuses on improving treatments for patients with various vascular diseases.

Latest Patents

One of Sutch's key inventions is a patent for a co-crystal of Ticagrelor, which is designed to enhance the efficacy of the compound in preventing arterial thrombotic complications. The co-crystal combines Ticagrelor with acetyl salicylic acid, creating a formulation that can be used in pharmaceutical compositions. This innovation aims to provide a more effective treatment for patients suffering from coronary artery, cerebrovascular, or peripheral vascular diseases.

Career Highlights

Sutch is associated with AstraZeneca AB, a leading global biopharmaceutical company. His work at AstraZeneca has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His patent portfolio includes 1 patent, showcasing his commitment to advancing medical science.

Collaborations

Throughout his career, Sutch has collaborated with esteemed colleagues, including Stephen David Cosgrove and David Thomas Jonaitis. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jonathan Charles Derrick Sutch is a prominent inventor whose work in pharmaceutical co-crystals has the potential to significantly impact the treatment of vascular diseases. His contributions to the field exemplify the importance of innovation in medicine.